Neogap
Developer of personalized cancer immunotherapy designed to precisely target and eliminate cancer. The company's product identifies optimal neoantigens to target, activate and multiply T-lymphocytes wi...
Valuation
$0
Share Price
N/A
Total Raised
$11.3M
Last Round
N/A